Sigyn Therapeutics (SIGY) News Today → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free SIGY Stock Alerts $5.25 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | finance.yahoo.comSigyn Therapeutics Reports First Quarter 2024 Financial ResultsMay 7, 2024 | finance.yahoo.comSigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"March 5, 2024 | finance.yahoo.comSigyn Therapeutics™ to Present at Tomorrow’s Emerging Growth ConferenceMarch 5, 2024 | finance.yahoo.comSigyn Therapeutics to Present at Tomorrow's Emerging Growth ConferenceMarch 5, 2024 | globenewswire.comSigyn Therapeutics™ to Present at Tomorrow's Emerging Growth ConferenceFebruary 21, 2024 | globenewswire.comSigyn Therapeutics™ Announces Filing of 2023 Annual Report on SEC Form 10-KFebruary 3, 2024 | finanznachrichten.deSigyn Therapeutics, Inc.: Sigyn Therapeutics Completes Reverse Stock SplitFebruary 2, 2024 | msn.comSigyn Therapeutics Announces 1-for-40 Reverse Stock SplitFebruary 1, 2024 | finance.yahoo.comSigyn Therapeutics Completes Reverse Stock SplitJanuary 30, 2024 | finanznachrichten.deSigyn Therapeutics, Inc.: Sigyn Therapeutics Announces Reverse Stock SplitJanuary 30, 2024 | finanznachrichten.deSigyn Therapeutics, Inc.: Sigyn Therapeutics Releases Letter to ShareholdersJanuary 30, 2024 | markets.businessinsider.comEQS-News: Sigyn Therapeutics Announces Reverse Stock SplitJanuary 30, 2024 | finance.yahoo.comSigyn Therapeutics Announces Reverse Stock SplitJanuary 4, 2024 | finance.yahoo.comSigyn Therapeutics Releases Letter to ShareholdersDecember 12, 2023 | finanznachrichten.deSigyn Therapeutics, Inc.: Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial OfficerDecember 12, 2023 | msn.comSigyn Therapeutics appoints Jerry DeCiccio as finance chiefDecember 12, 2023 | finance.yahoo.comSigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial OfficerNovember 15, 2023 | finanznachrichten.deSigyn Therapeutics, Inc.: Sigyn Therapeutics Reports Third Quarter 2023 Financial ResultsNovember 15, 2023 | msn.comSigyn Therapeutics Inc GAAP EPS of -$0.02November 14, 2023 | finance.yahoo.comSigyn Therapeutics Reports Third Quarter 2023 Financial ResultsOctober 4, 2023 | finance.yahoo.comSigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment ToxicitySeptember 15, 2023 | finance.yahoo.comSigyn Therapeutics to Present at Today’s Emerging Growth Conference and Tomorrow at the National Investment Bankers Association ConferenceJune 23, 2023 | morningstar.comRelay Therapeutics Inc Ordinary SharesMay 22, 2023 | fool.comBeam Therapeutics (NASDAQ: BEAM)May 17, 2023 | finance.yahoo.comSigyn Therapeutics Discloses “DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES” Patent Submission and Related ImmunePrep™ Trademark ApplicationMay 16, 2023 | finanznachrichten.deSigyn Therapeutics, Inc.: Sigyn Therapeutics Reports First Quarter 2023 Financial ResultsMay 16, 2023 | finance.yahoo.comSigyn Therapeutics Reports First Quarter 2023 Financial ResultsApril 11, 2023 | finance.yahoo.comSigyn Therapeutics™ Announces Appointment of Annette Marleau, Ph.D. as Chief Scientific OfficerMarch 31, 2023 | finance.yahoo.comSigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-KMarch 21, 2023 | forbes.comChinook TherapeuticsFebruary 25, 2023 | seekingalpha.comJounce Therapeutics downgraded to market perform at Raymond James on company restructuring Get Sigyn Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. SIGY Media Mentions By Week SIGY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SIGY News Sentiment▼0.000.76▲Average Medical News Sentiment SIGY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SIGY Articles This Week▼00▲SIGY Articles Average Week Get Sigyn Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Arch Therapeutics News Vivos Therapeutics News Intelligent Bio Solutions News NeuroMetrix News Avinger News Vapotherm News Titan Medical News Venus Concept News Sharps Technology News Assure News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SIGY) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sigyn Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.